[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gould et al., 2020 - Google Patents

Breath analysis for detection of viral infection, the current position of the field

Gould et al., 2020

Document ID
16250698103821551550
Author
Gould O
Ratcliffe N
Król E
de Lacy Costello B
Publication year
Publication venue
Journal of Breath Research

External Links

Snippet

The COVID-19 pandemic has highlighted the importance of rapid, cost effective, accurate, and non-invasive testing for viral infections. Volatile compounds (VCs) have been suggested for several decades as fulfilling these criteria. However currently very little work has been …
Continue reading at iopscience.iop.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/62—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating the ionisation of gases; by investigating electric discharges, e.g. emission of cathode
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples

Similar Documents

Publication Publication Date Title
Gould et al. Breath analysis for detection of viral infection, the current position of the field
Ibrahim et al. Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry
Ahmed et al. Exhaled volatile organic compounds of infection: a systematic review
US8518663B2 (en) Rapid detection of volatile organic compounds for identification of Mycobacterium tuberculosis in a sample
Chambers et al. Developments in novel breath tests for bacterial and fungal pulmonary infection
van Oort et al. The potential role of exhaled breath analysis in the diagnostic process of pneumonia—a systematic review
Kurada et al. breath analysis in inflammatory bowel diseases
Sperk et al. Utility of proteomics in emerging and re-emerging infectious diseases caused by RNA viruses
Parker et al. A validated method for the quantification of fosfomycin on dried plasma spots by HPLC–MS/MS: Application to a pilot pharmacokinetic study in humans
Berna et al. Breath metabolites to diagnose infection
Buszewski et al. A new approach to identifying pathogens, with particular regard to viruses, based on capillary electrophoresis and other analytical techniques
Foster et al. Targeted proteomics of human metapneumovirus in clinical samples and viral cultures
García-Gómez et al. Real-time high-resolution tandem mass spectrometry identifies furan derivatives in exhaled breath
Yoshinari et al. Matrix-assisted laser desorption and ionization time-of-flight mass spectrometry analysis for the direct detection of SARS-CoV-2 in nasopharyngeal swabs
Lin et al. Progress in understanding COVID-19: insights from the omics approach
Farne et al. Comparative metabolomic sampling of upper and lower airways by four different methods to identify biochemicals that may support bacterial growth
Ghosh et al. Breath-based diagnosis of infectious diseases: a review of the current landscape
Go et al. Mass spectrometry reveals specific and global molecular transformations during viral infection
Preianò et al. MALDI MS-based investigations for SARS-CoV-2 detection
Pinto et al. Identification of SARS-CoV-2 proteins from nasopharyngeal swabs probed by multiple reaction monitoring Tandem Mass Spectrometry
Danaher et al. Breath biomarkers of influenza infection
Bourgin et al. Diagnostic, prognostic and mechanistic biomarkers of COVID-19 identified by mass spectrometric metabolomics
Al-Sulaiti et al. Metabolomics approaches for the diagnosis, treatment, and better disease management of viral infections
de Almeida et al. MALDI (+) FT-ICR mass spectrometry (MS) combined with machine learning toward saliva-based diagnostic screening for COVID-19
Borras et al. Exhaled breath biomarkers of influenza infection and influenza vaccination